Lipella Pharmaceuticals Inc. Share Price
Equities
LIPO
US53630L1008
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | +2.36% | +3.45% | -26.47% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 5.7M 476M |
---|---|---|---|---|---|
Net income 2024 * | -3M -250M | Net income 2025 * | -5M -417M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.78
x | P/E ratio 2025 * |
-3.26
x | Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.57% |
1 day | +2.36% | ||
1 week | +3.45% | ||
Current month | +3.04% | ||
1 month | +7.91% | ||
3 months | -25.00% | ||
6 months | -34.78% | ||
Current year | -26.47% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 67 | 01/05/01 | |
Jonathan Kaufman
CEO | Chief Executive Officer | 58 | 01/05/01 |
Douglas Johnston
DFI | Director of Finance/CFO | 40 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Kaufman
CEO | Chief Executive Officer | 58 | 01/05/01 |
Founder | 67 | 01/05/01 | |
Byong Kim
BRD | Director/Board Member | 54 | 01/22/01 |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 0.75 | +2.36% | 24,511 |
13/24/13 | 0.7327 | +0.10% | 6,327 |
10/24/10 | 0.732 | -2.40% | 15,986 |
09/24/09 | 0.75 | +1.50% | 14,808 |
08/24/08 | 0.7389 | +1.92% | 5,488 |
Delayed Quote Nasdaq, May 15, 2024 at 02:00 am IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.47% | 5.7M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.32% | 21.25B | |
-5.99% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- LIPO Stock